Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
– Experienced oncology drug developer with more than two decades advancing treatments for solid tumors and…
News
Sorrento Announces Full Enrollment of Phase I Study of Intranasal STI-9199 (COVISHIELD™ IN), a Potent Neutralization Antibody Against Omicron BA.2 and All Variants of Concern
The Phase I safety and pharmacokinetic study in 24 healthy volunteers has completed enrollment. The…
Harpoon Therapeutics and Roche to Collaborate on Clinical Trials to Study Novel Immuno-Oncology Combination for Small Cell Lung Cancer
HPN328, Harpoon’s DLL3-targeting T cell engager, to be evaluated in combination with anti-PD-L1 antibody in…
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
LAS VEGAS, NV, May 02, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Digipath, Inc. (OTCQB:…
CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., May…
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
Leading medical technology company recognized for employee engagement and culture PALM BEACH GARDENS, Fla., May…
SciSparc Files Annual Report for Year Ended December 31, 2021 and Provides Corporate Update
TEL AVIV, Israel, May 02, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty…
Palisade Bio Provides Business Outlook and Highlights Expected Near-Term Pipeline Advancements
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on…
Healthy Extracts’ First Major Brand Influencer Launches New Line of Natural Health and Fitness Formulations on WhitneyJohns.com
Whitney Johns Product Line The New Whitney Johns Product Line includes BRAIN ACTIVATE (in gel…
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today…
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in…
Galecto to Participate at Upcoming Investor Conferences
BOSTON, May 02, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology…
NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting
SANTA ANA, Calif., May 02, 2022 (GLOBE NEWSWIRE) — NKGen Biotech Inc., a biotechnology company…
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)
Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of…
Ring Therapeutics Announces Publication Highlighting In Vivo Delivery and Tropism of the First Synthesized Human Anelloviruses Using a Recombinant Genome
Synthesized anellovirus particles demonstrated tissue-specific delivery in vivo CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE)…
aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results
Management to host conference call and webcast on May 9th at 5:00 pm EDT /…
Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels…
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9
DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease
DALLAS, May 02, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a company pioneering the…
Mersana Therapeutics to Host First Quarter 2022 Conference Call on May 9, 2022
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…